Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases

    December 2022 in “ Cells
    Robert Ramer, Burkhard Hinz
    New to cannabidiol? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This review examines the role of cannabinoid compounds in treating various skin conditions and suggests their potential as systemic and topical therapies, but it reports no new experimental results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document discusses the potential of cannabinoid compounds, particularly CBD and THC, in treating non-cancer skin diseases. The endocannabinoid system, which includes receptors and enzymes, plays a role in various skin functions and diseases. Cannabinoids have shown promise in treating conditions such as androgenetic alopecia, dermatitis, dermatomyositis, eczema, and psoriasis, among others. They can influence wound healing, scar formation, skin inflammation, and hair growth. For instance, activation of the CB1 receptor can promote the proliferation of hair follicle epithelial progenitor cells, suggesting potential treatments for alopecia. However, more research is needed to understand the exact mechanisms and potential side effects. The document also highlights the need for future clinical trials to explore combining cannabinoids with other drugs for enhanced therapeutic effects.
    Discuss this study in the Community →

    Research cited in this study

    29 / 29 results